Friday, 30 December 2016

Growth hormone deficiency drug from OPKO and Pfizer fails study

(Reuters) - OPKO Health Inc said on Friday its experimental drug for growth hormone deficiency did not provide a statistically significant benefit over a placebo in a late-stage study.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)